About: http://webisa.webdatacommons.org/385689047

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	The trial was an equivalence trial designed to demonstrate that capecitabine monotherapy was at least equivalent to 5-FU/LV in achieving 3-year disease-free survival.
http://www.w3.org/ns/prov#wasQuotedFrom	york.ac.uk